⭐ About the Founder — Dr. Dongmyung Park

​

Founder & Director, Advanced Social Policy Institute
FDA Regulatory Consultant · Legal Scholar (Ph.D. in Law)

​

​

Profile Overview

​

Dr. Dongmyung Park is a distinguished legal scholar and regulatory strategist with over two decades of experience in public policy, administrative law, and government regulatory systems.
 

As the founder of the Advanced Social Policy Institute, Dr. Park integrates legal reasoning, administrative expertise, and regulatory science to support companies entering the U.S. market through FDA compliance.

​

He is also a collaborator with FDA ASIA LLC, a certified U.S. FDA official agent, expanding Korea–U.S. regulatory cooperation through joint research, training programs, and the establishment of a Regulatory Science Center in Korea (scheduled for 2026).

​

Academic & Professional Background

​

• Ph.D. in Law, Chonnam National University Graduate School

• Completed Ph.D. coursework in Public Administration, Sungkyunkwan University

• M.A. in Social Welfare, Sungkyunkwan University

• Guest and adjunct professor at major Korean universities for over 20 years

• Lecturer at the National Assembly Legislative Training Institute (국회의정연수원)

 

His academic work spans administrative law, regulatory governance, public policy design, and global compliance frameworks.

​

​

Government & Public Sector Experience

​

Dr. Park has served in high-level advisory and administrative roles, including:

• Senior Specialist (전문위원), Seoul Metropolitan Council

• Settlement Audit Commissioner, Gangnam-gu (결산검사위원)

• Policy advisor for multiple city and provincial councils across Korea

• Lead researcher for numerous public-sector regulatory and policy studies

• Designer of capacity-building programs for local legislatures and government agencies

• ​

These experiences provide him with a deep understanding of statutory interpretation, administrative due process, and risk management — all essential competencies for FDA regulatory consulting.

​

​

FDA-Related Competencies & Global Collaboration

​

Dr. Park’s FDA consulting framework is reinforced through a strategic partnership with FDA ASIA LLC, led by CEO Kisu Kim, a U.S.-based FDA official agent.

​

Together, they deliver:

• Industry-specific regulatory strategies

• Labeling and claims compliance reviews

• FDA facility registration & documentation support

• Training programs for companies, local governments, and policy institutions

• AI-based regulatory science and global market-entry intelligence

 

This partnership enables Korean companies to receive U.S. FDA-level guidance without geographical barriers.

​

​

Core Strengths as a Regulatory Consultant

​

1. Legal Interpretation + Regulatory Science

​

FDA regulations are complex legal frameworks.
Dr. Park’s expertise ensures a precise understanding of compliance requirements across statutes, guidance documents, and administrative precedents.

​

2. Policy Engineering & Global Compliance Strategy

​

His background enables the design of end-to-end compliance pathways optimized for each product category (Food, Supplement, Cosmetic, Device, OTC, Veterinary).

​

3. Risk Anticipation Ability

​

He applies public-sector audit methodologies and FDA enforcement data to predict and mitigate regulatory risks.

​

4. Education & Capacity-Building Expertise

​

Over 20 years of training experience strengthens his ability to communicate complex FDA concepts in a practical, actionable manner.

​

​

Vision & Mission

​

Dr. Park aims to build a Korea–U.S. regulatory bridge, helping Korean companies enhance global competitiveness by ensuring compliance with the world’s most stringent regulatory system — the U.S. FDA.

​

His mission is clear:

“To provide companies with a transparent, predictable, and legally robust pathway to the U.S. market through FDA compliance.”

​

​

Representative Projects & Initiatives

​

• MOU signing with FDA ASIA LLC for joint regulatory science programs

• Development of AI-enabled FDA risk analysis models

• Legislative support for local governments on food, agriculture, and biotech industry promotion

• Consulting for companies preparing FDA submissions across multiple industries

• Establishment of the FDA–ASPI Regulatory Science Center (2026 예정)

​

​

⭐ Short Version for Intro / Profile Summary

​

“Dr. Dongmyung Park is a legal scholar and FDA regulatory strategist specializing in U.S. compliance, risk analysis, and industry-specific approval pathways. With 20+ years in public policy, he integrates legal reasoning and regulatory science to support Korean companies entering the U.S. market.”

​